Author:
Kamat Ashish M.,Vlahou Antonia,Taylor John A.,Hudson M´Liss A.,Pesch Beate,Ingersoll Molly A.,Todenhöfer Tilmann,van Rhijn Bas,Kassouf Wassim,Barton Grossman H.,Behrens Thomas,Chandra Ashish,Goebell Peter J.,Palou Juan,Sanchez-Carbayo Marta,Schmitz-Dräger Bernd J.
Reference42 articles.
1. van Rhijn BWG, Catto JW, Goebell PJ, Knüchel R, Shariat SF, Sanchez-Carbayo M, et al. Molecular markers for urothelial bladder cancer prognosis: towards implementation in clinical practice. Urol Oncol [this issue].
2. Considerations on the use of urine markers in the management of patients with low/intermediate risk non muscle-invasive bladder cancer;Schmitz-Dräger;Urol Oncol,2014
3. Sensitivity and specificity of commonly available bladder tumor markers versus cytology: results of a comprehensive literature review and meta-analyses;Lotan;Urology,2003
4. Urine markers for bladder cancer surveillance: a systematic review;van Rhijn;Eur Urol,2005
5. Systematic review of the clinical effectiveness and cost-effectiveness of photodynamic diagnosis and urine biomarkers (FISH, ImmunoCyt, NMP22) and cytology for the detection and follow-up of bladder cancer;Mowatt;Health Technol Assess,2010
Cited by
29 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献